Please login to the form below

Not currently logged in
Email:
Password:

New industry standards group launched

Align Clinical CRO will improve clinical trial collaboration

Align Clinical CROBiopharmaceutical solutions organisation company Syneos Health has helped to establish Align Clinical CRO, a new industry standards group which aims to improve clinical trial collaboration and execution.

The new organisation is said to represent a ‘first-ever global effort’ where CROs are joining forces to develop open technology standards to transform clinical trial operations.

Officially launched late last month, Align Clinical CRO brings together six CROs and cloud computing group Veeva Systems to help create open technology standards intended to simplify trial execution and improve the productivity and efficiency of clinical trials for sponsors.

Rachel Stahler, chief information officer for Syneos Health, said: “Smart collaboration - identifying better and faster methods to deliver medicines to patients - is at the heart of everything we do at Syneos Health.

“Within our organisation, we’ve purposefully removed the silos between the clinical and commercial disciplines to provide solutions that improve operational delivery and enable our customers to speed therapies to patients.”

Syneos Health, formerly known as INC Research and InVentiv Health, expects to bring industry knowledge to the new offering, along with clinical and commercial expertise and integrated, multi-disciplinary perspectives.

Henry Levy, president of Align Clinical CRO, said: “There’s tremendous potential to enhance clinical trial execution through common technology standards that will benefit the entire industry.

“Align Clinical CRO represents an important industry collaboration to improve the trial processes and how the industry works together to accelerate drug development.”

Article by
Gemma Jones

5th April 2018

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

Dimitri Azzopardi
Case-study for thalassaemia: Dimitri Azzopardi
An in-depth look at beta thalassaemia for Rare Disease Day...
Delivering change through better rare disease communications
OPEN Health’s Richard Jones, Gemma Allen and Charlotte Richards discuss how pharma can utilise tools, channels and stakeholders to deliver change and enable better outcomes....
Interim analysis clinical trials
Assessing the value of interim analyses in clinical trials
Why its important and when its needed...

Infographics